{"id":552,"date":"2019-05-10T04:13:43","date_gmt":"2019-05-10T04:13:43","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=552"},"modified":"2024-06-20T13:01:05","modified_gmt":"2024-06-20T11:01:05","slug":"programa-de-gens-malaltia-i-terapia","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-gens-malaltia-i-terapia\/","title":{"rendered":"Programa de Gens, Malaltia i Ter\u00e0pia"},"content":{"rendered":"\n

\n\t\tPrograma de Gens, Malaltia i Ter\u00e0pia\n\t<\/h1>\n

\n\t\tResum\n\t<\/h3>\n\t

El nostre programa \u00e9s multidisciplinari, format per IPs responsables de l\u00ednies de recerca de formaci\u00f3 espec\u00edfica en les \u00e0rees de Gen\u00e8tica Humana, Bioqu\u00edmica,\u00a0 Biologia Molecular i Cel\u00b7lular en el camp de la Biomedicina, que amb diverses aproximacions experimentals\u00a0 enriqueixen l’abordatge transversal dels projectes de recerca que es desenvolupen per tal d’aprofundir en les bases i la fisiopatologia de malalties gen\u00e8tiques humanes, tan monog\u00e8niques com complexes, aix\u00ed com malalties que cursen amb processos inflamatoris.<\/p>\n

La base funcional del nostre grup inclou un programa cient\u00edfic-t\u00e8cnic de formaci\u00f3 de personal investigador, estimulant la incorporaci\u00f3 de noves tecnologies i contribuint a augmentar la producci\u00f3 cient\u00edfica d’excel\u00b7l\u00e8ncia i la transfer\u00e8ncia, dels coneixements adquirits i dels resultats obtinguts, a la societat en l’\u00e0rea de Biomedicina. A m\u00e9s, es prioritza la translaci\u00f3 dels resultats a la societat mitjan\u00e7ant col\u00b7laboracions acad\u00e8miques externes, amb la ind\u00fastria farmac\u00e8utica i biotecnol\u00f2gica, i la generaci\u00f3 de patents d’utilitat biom\u00e8dica.<\/p>\n

Els objectius del nostre grup de recerca s’emmarquen dins del repte 1 del programa Horizon 2020 “Salut, canvi demogr\u00e0fic i benestar, i en concret en l’objectiu 1.1 “comprensi\u00f3 de la salut, el benestar i la malaltia”, en el sub-apartat 1.1.2 “comprendre la malaltia”.<\/p>\n\t\t\t\t\"grup_sense_foto_-_gens\"\n\t

\n
\n
\n
\n
\n
\nEl Programa de Gens, Malaltia i Ter\u00e0pia t\u00e9 com a objectiu principal l’estudi de les bases gen\u00e8tiques i moleculars de les malalties heredit\u00e0ries i\/o dels processos immunoinflamatoris utilitzant estrat\u00e8gies gen\u00f2miques, transcrit\u00f2miques i prote\u00f2miques\n<\/section>\n<\/header>\n<\/section>\n<\/header>\n<\/section>\n<\/header>\n

4<\/h2>\n

Grups<\/h2>\n

6<\/h2>\n

Investigadors principals<\/h2>\n

\n\t\tGrups de Recerca\n\t<\/h3>\n\t\t\t\t\n\t\t\t\t\"grup_sense_foto_-_gens_1\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Nunes\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tGen\u00e8tica molecular humana\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"rat_hippocampus_stained_with_antibody_to_neun_green_myelin_basic_protein_red_and_dna_blue\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Estevez\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tFisiologia i patologia de la relaci\u00f3 funcional glia-neurona\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"Modeling-human-diseases-in-C-elegans2s\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Cer\u00f3n\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tModels de malaltia en C.elegans\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\n\t\t\t\t\"902_aran\"\n\t\t\t\t<\/a>\n
\n\t\t\n\t\tGrup Aran\n\t\t<\/a>\n\t<\/h6>\n
\n\t\t\n\t\tProcessos immune-inflamatoris i ter\u00e0pia g\u00e8nica\n\t\t<\/a>\n\t<\/h6>\n\t\t\t\t\"avatar-188\"\n

\n\t\tCOORDINADOR DE PROGRAMA\n\t<\/h4>\n

\n\t\tCer\u00f3n Madrigal, Juli\u00e1n\n\t<\/h4>\n

\n\t\tCOORDINADOR DOCENT\n\t<\/h4>\n

\n\t\t\n\t\tjceron@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tNot\u00edcies relacionades\n\t<\/h3>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tMor Virginia Nunes, cap del grup de Gen\u00e8tica Molecular Humana i una de les fundadores de l’IDIBELL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t25\/05\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescobreixen potencials biomarcadors per a la infertilitat masculina: la composici\u00f3 dels microRNAs i les seves isoformes<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t28\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescriuen un nou f\u00e0rmac biol\u00f2gic capa\u00e7 de restablir l’home\u00f2stasi del sistema immune<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t31\/10\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls ARNs petits presents al semen \u00fatils com a biomarcadors per determinar l’origen de l’azoosp\u00e8rmia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/06\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa fundaci\u00f3 hna col\u00b7labora en el desenvolupament d’un nou f\u00e0rmac contra les malalties inflamat\u00f2ries intestinals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t19\/12\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tConfirmen la utilitat d’un microARN en semen com a biomarcador per al diagn\u00f2stic d’azoospermia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/10\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn projecte de Josep Maria Aran rep l’impuls de les ajudes CaixaResearch Validate<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/07\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl genotipat a gran escala permet identificar la causa molecular de dos casos de globozoosp\u00e8rmia familiar<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/06\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEstableixen un nou sistema d’edici\u00f3 gen\u00e8tica en animals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tPresenten una nova prote\u00efna recombinant que reverteix l’estat proinflamatori de c\u00e8l\u00b7lules de pacients amb lupus<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"

Programa de Gens, Malaltia i Ter\u00e0pia Resum El nostre programa \u00e9s multidisciplinari, format per IPs responsables de l\u00ednies de recerca de formaci\u00f3 espec\u00edfica en les \u00e0rees de Gen\u00e8tica Humana, Bioqu\u00edmica,\u00a0 Biologia Molecular i Cel\u00b7lular en el camp de la Biomedicina, que amb diverses aproximacions experimentals\u00a0 enriqueixen l’abordatge transversal dels projectes de recerca que es desenvolupen […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":530,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-552","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 09:29:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=552"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/552\/revisions"}],"predecessor-version":[{"id":26038,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/552\/revisions\/26038"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/530"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}